Clinical Trials Browser

Withdrawn × Carcinoma, Hepatocellular × Cyclophosphamide × Clear all

NCT04093648 2020-05-20

T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Phase 2 Withdrawn

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular